CLINICAL_TRIALS
trial_result
· 2022-01-04
Clinical Trial Update: Management of Abdominal Pain in Acute Gastroenteritis Patients With Hyoscine Butylbromide [Phase 4]
Summary
Phase 4 clinical trial update evaluating hyoscine butylbromide for managing abdominal pain in patients with acute gastroenteritis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ankara City Hospital Bilkent | Conditions: Acute Gastroenteritis, Abdominal Pain | Phase 4 | Status: COMPLETED